ARCHIVES

An “insurgency” targets randomized trials, demands access to investigational drugs.

This article is from The Cancer Letter archive.

Vol. 31 No. 31 | August 5, 2005

Download PDF Visit The Full Archive

Related Articles

Diptheria Toxin Prompts Immune System To Kill Cancer

December 29, 2006

Proposed Surveillance Model Aims To Reduce Post-Treatment Pain

April 27, 2012

In Brief: House Appropriations Bill Marked Up, Lid Clamped On; Wells Named DCT Board Chairman

July 6, 1984

ACS Medals Of Honor To Bonadonna, Hsu, Louis Sullivan

December 13, 1991

FDA Advisors Recommend Approval Of Leucovorin, Hexamethylmelamine

June 16, 1989

Improved Prediction Of Cancer To Increase Pressure On Prevention, Greenwald Says

August 15, 1986